Cover Image
Read Now

Applicability of the evidence regarding intensive glycemic control and self-monitored blood glucose to Medicare patients with type 2 diabetes

This technology assessment report on intensive glycemic control and self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes mellitus is prepared by the Tufts-New England Medical Center Evidence-based Practice Center (Tufts-NEMC EPC) for a Medicare Evidence Development and Coverage A...

Full description

Bibliographic Details
Main Author: Balk, Ethan
Corporate Authors: United States Agency for Healthcare Research and Quality, Tufts Evidence-based Practice Center
Format: eBook
Language:English
Published: Rockville, Maryland Agency for Healthcare Research and Quality 2007, Sepember 10, 2007
Series:Technology assessment report
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
LEADER 02030nam a2200253 u 4500
001 EB002072069
003 EBX01000000000000001212159
005 00000000000000.0
007 tu|||||||||||||||||||||
008 220923 r ||| eng
100 1 |a Balk, Ethan 
245 0 0 |a Applicability of the evidence regarding intensive glycemic control and self-monitored blood glucose to Medicare patients with type 2 diabetes  |h Elektronische Ressource  |c Tufts-NEMC EPC ; Ethan Balk, Eleonora Teplinsky, Thomas Trikalinos, Priscilla Chew, Mei Chung, Joseph Lau, Anastassios Pittas 
260 |a Rockville, Maryland  |b Agency for Healthcare Research and Quality  |c 2007, Sepember 10, 2007 
300 |a 1 PDF file (83 pages) 
505 0 |a Includes bibliographical references 
710 2 |a United States  |b Agency for Healthcare Research and Quality 
710 2 |a Tufts Evidence-based Practice Center 
041 0 7 |a eng  |2 ISO 639-2 
989 |b NCBI  |a National Center for Biotechnology Information 
490 0 |a Technology assessment report 
500 |a Title from PDF title page 
856 4 0 |u https://www.ncbi.nlm.nih.gov/books/NBK258777  |3 Volltext 
082 0 |a 610 
520 |a This technology assessment report on intensive glycemic control and self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes mellitus is prepared by the Tufts-New England Medical Center Evidence-based Practice Center (Tufts-NEMC EPC) for a Medicare Evidence Development and Coverage Advisory Committee (MedCAC) meeting. The primary goal of the report is to describe the applicability of the larger, long-duration studies to the nondialysis Medicare population (i.e., people at least 65 years old). The specific questions addressed are described in the Methods chapter (Chapter 2). The Center for Medicare and Medicaid Services (CMS) also requested a brief narrative review of diabetes (both type 1 and type 2), its epidemiology in the US, complications due to the disease and its treatment, intensive glycemic control, and patient monitoring of glycemia 

Similar Items